Managing Pruritus in Advanced Chronic Disease

Area of Science:

• Nephrology
• Dermatology
• Pharmacology

Background:

• Pruritus significantly impacts patients with chronic diseases, yet effective treatments are lacking.
• Current therapies like antihistamines are often ineffective for systemic itch.
• Hydroxyzine, a common treatment for kidney failure-related pruritus, is becoming unavailable.

Purpose of the Study:

• To review the mechanisms of itch in advanced non-cancer organ failure.
• To discuss current and potential therapies for systemic pruritus in this population.
• To address the gap in treatment options due to the discontinuation of hydroxyzine.

Main Methods:

• Systematic review of existing literature on pruritus in chronic non-cancer diseases.
• Analysis of pathogenesis and treatment strategies for systemic itch.
• Focus on studies related to advanced organ failure.

Main Results:

• Antihistamines show limited efficacy in treating systemic pruritus.
• Hydroxyzine is a frequently used but potentially unavailable treatment for uremic pruritus.
• Literature on itch in chronic non-cancer diseases is often based on small cohort studies.

Conclusions:

• There is a critical need for improved understanding and treatment of systemic pruritus in chronic organ failure.
• The unavailability of hydroxyzine necessitates exploration of alternative therapeutic approaches.
• Further research with larger studies is required to establish effective treatments for chronic disease-related itch.